Do The Twins Need Bullpen Help?

This Twins front office has taken a few big swings on relief additions in their tenure and often whiffed. From Addison Reed to Jorge Lopez, it’s easy to see why the Twins may have developed a belief that bullpens aren’t worth majorly investing in. With a decline in payroll headed into 2024, we should expect them to show a good bit of restraint again. They would certainly be justified in doing so.

Many believed the Twins could have benefitted from one more high-leverage reliever headed in 2023. It never hurts, after all. The Twins had reason to believe the top end of their bullpen was a strength between Jhoan Duran, Griffin Jax, and Lopez. Of course, Griffin Jax piled up blown leads early, and Lopez was eventually DFAed. Luckily, Brock Stewart emerged from Triple-A, and Jax righted the ship down the stretch to still have a formidable top of the bullpen by season’s end.

This trio will return in 2024, assuming good health. Duran is likely the undisputed closer at this point. A case can be made to slot Stewart in as the setup man after he struck out nearly 36% of the hitters he faced, and Jax had a down season by his standards. Either way, this group combined for just over 155 innings in 2023 with a cumulative 3.1 Wins Above Replacement. It’s a back end of a bullpen many competitive teams would envy on paper.

Caleb Thielbar should be back as a high-leverage, left-handed reliever capable of facing both righties and lefties. The question, of course, is health with the 36-year-old after repeated oblique issues limited him to just over 30 innings. He still struck out over 36% of opposing hitters and posted a 3.23 ERA on the season. Emilio Pagán’s departure will be noteworthy, though it’s important to remember that while his numbers were great, he pitched almost solely in low leverage.

The problem at times last season was the middle relief group. The Twins cycled in several arms, hoping a few would stick, and it cost them some wins. Jovani Moran looked to build on a solid 2022 season and couldn’t do so. He’s now undergoing Tommy John surgery and is expected to miss all of 2024.

Jorge Alcala has never really put it all together, and he has health questions of his own. Players like Cole Sands just never did enough to stick around.

Luckily, down the stretch, the Twins finally gave Kody Funderburk a shot. In 12 innings, he allowed one run and stuck out over 40% of the hitters he faced. It’s a small sample, but the lefty has a history of retiring hitters from both sides of the plate while picking up a healthy amount of strikeouts.

There’s at least a tiny hope that a few other internal options emerge to fill the middle innings.Jordan Balazovic’s MLB debut was unsuccessful, but if he is fully prepared as a traditional one-inning reliever, he may rediscover the talent that once made him a top prospect. Josh Winder began throwing a two-seam fastball down the stretch that would hopefully solve the fastball woes that have held him back despite a solid secondary pitch mix.

The Twins are in a better spot with the bullpen than in recent years. There are plenty of red flags, both health and performance-wise, but that’s to be expected on any roster. We may see them add a reliever this winter; it’s never a bad idea. It may be likelier that whoever they bring in is more of a flier for a few million dollars or even a waiver claim.

The odds of the Twins bringing in a big-time arm for the back innings, at least at market price, are extremely low. With the foundation they have in place and the payroll space they’re working with, we may see them more or less stand pat. Unlike in some recent years, doing so would be more justified. Do you agree?

— Latest Twins coverage from our writers
— Recent Twins discussion in our forums
— Follow Twins Daily via , or
— Become a Twins Daily Caretaker